Ajanta Pharma: Pls find enclosed Financial Results for the quarter ended 30.09.2026
Ajanta Pharma (AJANTPHARM) filed a disclosure titled "Pls find enclosed Financial Results for the quarter ended 30.09.2026". The company is valued at about ₹44,613 crore.
What happened
Ajanta Pharma (AJANTPHARM) filed a disclosure with the exchanges on 30 October 2026 at 12:55 PM titled "Pls find enclosed Financial Results for the quarter ended 30.09.2026".
Company snapshot
Ajanta Pharma is a mid-cap company in the Healthcare sector, with a market value of about ₹44,613 crore.
The stock last traded at ₹3,570.9, against a 52-week range of ₹2,430–₹3,796 (5.9% below the high).
Before this filing the shares had moved −1.9% over the month and +0.7% over three months. Average daily turnover over the last 20 sessions was about ₹33.84 crore.
Promoters held 63.48% at the end of Q1 FY27, down 2.77% points from the previous quarter; 22.53% of promoter shares were pledged. Foreign institutions owned 7.68% and domestic institutions 21.80%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 1,303 | 255.3 | 20.44 |
| Q2 FY26 | 1,354 | 260.2 | 20.83 |
| Q3 FY26 | 1,375 | 273.8 | 21.91 |
| Q4 FY26 | 1,422 | 266.7 | 21.35 |
| Q1 FY27 | 1,626 | 330 | 26.75 |
What history shows
This is not the company's first results disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.
Across 300 similar disclosures by other Healthcare companies, shares moved +1.1% on average the next day and +1.9% over five days; 55% of them rose the next day.
Market-wide, 10,043 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 30 October 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- Ajanta Pharma promoter Aayush Agrawal pledges 30,000 shares
- Ajanta Pharma Ltd. Rallies 5.14% and Approaches 50 DMA Resistance — A Key Technical Test Ahead
- Midcap Low Debt Stocks 2026: Dixon, Dabur, Mphasis, Ajanta Pharma
- Pharma sector stocks today, October 27: Mankind Pharma jumps 8.4%, Aarti Drugs gains 3.88%, Ajanta Pharma up 3.37%
- Ajanta Pharma: Promoter Pledges 30,000 Shares
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.